These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34432564)

  • 21. The Critical Role of the Antimicrobial Peptide LL-37/ CRAMP in Protection of Colon Microbiota Balance, Mucosal Homeostasis, Anti-Inflammatory Responses, and Resistance to Carcinogenesis.
    Zhang M; Liang W; Gong W; Yoshimura T; Chen K; Wang JM
    Crit Rev Immunol; 2019; 39(2):83-92. PubMed ID: 31679249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The C. difficile clnRAB operon initiates adaptations to the host environment in response to LL-37.
    Woods EC; Edwards AN; Childress KO; Jones JB; McBride SM
    PLoS Pathog; 2018 Aug; 14(8):e1007153. PubMed ID: 30125334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of microbiota and innate immunity in recurrent Clostridium difficile infection.
    Bibbò S; Lopetuso LR; Ianiro G; Di Rienzo T; Gasbarrini A; Cammarota G
    J Immunol Res; 2014; 2014():462740. PubMed ID: 24995345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No evidence of pathogenic involvement of cathelicidins in patient cohorts and mouse models of lupus and arthritis.
    Kienhöfer D; Hahn J; Schubert I; Reinwald C; Ipseiz N; Lang SC; Borràs ÈB; Amann K; Sjöwall C; Barron AE; Hueber AJ; Agerberth B; Schett G; Hoffmann MH
    PLoS One; 2014; 9(12):e115474. PubMed ID: 25535966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Entamoeba histolytica induces intestinal cathelicidins but is resistant to cathelicidin-mediated killing.
    Cobo ER; He C; Hirata K; Hwang G; Tran U; Eckmann L; Gallo RL; Reed SL
    Infect Immun; 2012 Jan; 80(1):143-9. PubMed ID: 22083705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of GM-CSF in the inflammatory cytokine network that regulates neutrophil influx into the colonic mucosa during Clostridium difficile infection in mice.
    McDermott AJ; Frank CR; Falkowski NR; McDonald RA; Young VB; Huffnagle GB
    Gut Microbes; 2014 Jul; 5(4):476-84. PubMed ID: 25045999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycine fermentation by
    Rizvi A; Vargas-Cuebas G; Edwards AN; DiCandia MA; Carter ZA; Lee CD; Monteiro MP; McBride SM
    Infect Immun; 2023 Oct; 91(10):e0031923. PubMed ID: 37754683
    [No Abstract]   [Full Text] [Related]  

  • 28. Human monoclonal antibodies against Clostridium difficile toxins A and B inhibit inflammatory and histologic responses to the toxins in human colon and peripheral blood monocytes.
    Koon HW; Shih DQ; Hing TC; Yoo JH; Ho S; Chen X; Kelly CP; Targan SR; Pothoulakis C
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3214-23. PubMed ID: 23629713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasal Immunization with the C-Terminal Domain of Bcla3 Induced Specific IgG Production and Attenuated Disease Symptoms in Mice Infected with
    Maia AR; Reyes-Ramírez R; Pizarro-Guajardo M; Saggese A; Ricca E; Baccigalupi L; Paredes-Sabja D
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933117
    [No Abstract]   [Full Text] [Related]  

  • 30. The P2Y6 receptor mediates Clostridium difficile toxin-induced CXCL8/IL-8 production and intestinal epithelial barrier dysfunction.
    Hansen A; Alston L; Tulk SE; Schenck LP; Grassie ME; Alhassan BF; Veermalla AT; Al-Bashir S; Gendron FP; Altier C; MacDonald JA; Beck PL; Hirota SA
    PLoS One; 2013; 8(11):e81491. PubMed ID: 24278446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune responses to Clostridium difficile infection.
    Madan R; Petri WA
    Trends Mol Med; 2012 Nov; 18(11):658-66. PubMed ID: 23084763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colonic epithelial cathelicidin (LL-37) expression intensity is associated with progression of colorectal cancer and presence of CD8
    Porter RJ; Murray GI; Alnabulsi A; Humphries MP; James JA; Salto-Tellez M; Craig SG; Wang JM; Yoshimura T; McLean MH
    J Pathol Clin Res; 2021 Sep; 7(5):495-506. PubMed ID: 33988317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Anti-Microbial Peptide LL-37/CRAMP Is Elevated in Patients with Liver Diseases and Acts as a Protective Factor during Mouse Liver Injury.
    Wertenbruch S; Drescher H; Grossarth V; Kroy D; Giebeler A; Erschfeld S; Heinrichs D; Soehnlein O; Trautwein C; Brandenburg LO; Streetz K
    Digestion; 2015; 91(4):307-17. PubMed ID: 25998843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clostridium difficile modulates host innate immunity via toxin-independent and dependent mechanism(s).
    Jafari NV; Kuehne SA; Bryant CE; Elawad M; Wren BW; Minton NP; Allan E; Bajaj-Elliott M
    PLoS One; 2013; 8(7):e69846. PubMed ID: 23922820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anti-microbial peptide LL-37/CRAMP levels are associated with acute heart failure and can attenuate cardiac dysfunction in multiple preclinical models of heart failure.
    Zhou Q; Pan LL; Xue R; Ni G; Duan Y; Bai Y; Shi C; Ren Z; Wu C; Li G; Agerberth B; Sluijter JP; Sun J; Xiao J
    Theranostics; 2020; 10(14):6167-6181. PubMed ID: 32483446
    [No Abstract]   [Full Text] [Related]  

  • 36. Clostridioides difficile and the Microbiota Early in Life.
    Semon AK; Keenan O; Zackular JP
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S3-S7. PubMed ID: 34791400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Butyrate-Producing Bacterium
    Hayashi A; Nagao-Kitamoto H; Kitamoto S; Kim CH; Kamada N
    J Immunol; 2021 Apr; 206(7):1576-1585. PubMed ID: 33597149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of dietary fibers on
    Wu Z; Xu Q; Wang Q; Chen Y; Lv L; Zheng B; Yan R; Jiang H; Shen J; Wang S; Wang K; Xia J; Han S; Li L
    Front Cell Infect Microbiol; 2022; 12():1028267. PubMed ID: 36439215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.
    Hirota SA; Iablokov V; Tulk SE; Schenck LP; Becker H; Nguyen J; Al Bashir S; Dingle TC; Laing A; Liu J; Li Y; Bolstad J; Mulvey GL; Armstrong GD; MacNaughton WK; Muruve DA; MacDonald JA; Beck PL
    Infect Immun; 2012 Dec; 80(12):4474-84. PubMed ID: 23045481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The xenobiotic sensing pregnane X receptor regulates tissue damage and inflammation triggered by C difficile toxins.
    Erickson SL; Alston L; Nieves K; Chang TKH; Mani S; Flannigan KL; Hirota SA
    FASEB J; 2020 Feb; 34(2):2198-2212. PubMed ID: 31907988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.